Delivery Order SPE2DB25D3110-SPE2DB25FTEBW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,406.60 to AmerisourceBergen Drug Corp for ZENPEP (pancrelipase) 40,000 unit capsules in quantities of 100 per bottle. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a...
- The Defense Logistics Agency awarded a $4,610.82 delivery order to AmerisourceBergen Drug Corp for ZENPEP DR 60,000 unit capsules (100-count bottles) on July 30, 2025, with a completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for ZENPEP DR 40,000 unit capsules (100-count bottles) with a ceiling value of $4,127.11. This firm fixed price delivery order, which achieves ultimate completion on July 24, 2025, represents a competitively awarded non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at ten thousand five hundred ninety-nine dollars and sixteen cents ($10,599.16) to Amerisourcebergen Drug Corporation for Zenpep DR 40,000 unit capsules. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania from September 11 through September 12, 2023. The delivery order is placed against an existing indefinite-delivery/indefinite-quantity contract vehicle to...
- This is a $9,017.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,908,548 units of the drug ZENPEP DR 40,000 UNIT CAPSULE 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,199.06 contract is for the supply of 4,567,790,837 units of the drug ZENPEP (40,000 units per capsule, 100 capsules per bottle). The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,261 delivery order to Amerisourcebergen Drug Corporation for 40,000 units of the Zenpep DR 40,000 unit capsule. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support the Defense Logistics Agency's medical supply needs. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any broader contracts held by Amerisourcebergen....
- This federal contract award is a delivery order valued at $11,787.39 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S, a medical product, with a period of performance through February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,141.71 firm fixed-price delivery order covers the procurement of 4,564,544,240 units of the drug ZENPEP DR 20,000 in 100-count capsule containers. The contract has a completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- The Defense Logistics Agency Troop Support Medical awarded a $13,440 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 capsules of the 40,000 unit Zenpep DR pancreatic enzyme medication. Amerisourcebergen Drug Corp will fulfill the order as a division of its parent company, national pharmaceutical distributor Amerisourcebergen Corporation, by September 29, 2023 from its facility in Conshohocken, Pennsylvania. The delivery order was issued under an existing DLA medical...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEBWDelivery Order
The Defense Logistics Agency awarded a $9,447.87 delivery order to AmerisourceBergen Drug Corp for 100 capsule bottles of Zenpep DR 40,000 unit strength. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, employs firm fixed price pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that authorizes the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. Zenpep is a pancrelipase enzyme replacement therapy used to treat pancreatic insufficiency. This delivery order represents routine pharmaceutical replenishment within AmerisourceBergen's extensive federal medical supply portfolio, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen's status as a prime vendor for DLA reflects its critical role in sustaining the military health system's pharmaceutical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 8/12/25 |